Finally, USP3 gene knockout using a CRISPR/Cas9 system in neuroblastoma cell lines resulted in reduced cell viability, anchorage-independent growth, migration, and invasion (Fig. 7). The gene discussed is USP3; the disease is neuroblastoma.